MetaVia Financials

MTVA Stock

1.70 0.09 5.03%

Based on the key measurements obtained from MetaVia's financial statements, MetaVia is not in a good financial situation at this time. It has a very high odds of going through financial crisis in March. At present, MetaVia's Other Current Liabilities is projected to increase significantly based on the last few years of reporting. The current year's Accounts Payable is expected to grow to about 4.7 M, whereas Total Assets are forecasted to decline to about 16.7 M.

Yuan Drop

Covid

Interest Hikes

MetaVia Balance Sheet Chart

At present, MetaVia's Other Current Liabilities is projected to increase significantly based on the last few years of reporting. The current year's Accounts Payable is expected to grow to about 4.7 M, whereas Total Assets are forecasted to decline to about 16.7 M.

Total Assets Short Long Term Debt Total Total Current Liabilities Accounts Payable

Key indicators impacting MetaVia's financial strength include:

Current Value

Last Year

Change From Last Year

10 Year Trend

Current Ratio

1.66

1.75

Notably Down

Pretty Stable

The financial analysis of MetaVia is a critical element in measuring its lifeblood. Investors should carefully consider MetaVia's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.

Net Income

(26.07 Million)

Build AI portfolio with MetaVia Stock

Please note, the presentation of MetaVia's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, MetaVia's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of MetaVia's management manipulating its earnings.

MetaVia Stock Summary

MetaVia competes with Lisata Therapeutics, NuCana PLC, Exicure, Enlivex Therapeutics, and Klotho Neurosciences. MetaVia is entity of United States. It is traded as Stock on NASDAQ exchange.

Specialization	Health Care, Pharmaceuticals, Biotechnology & Life Sciences
Instrument	USA Stock View All
Exchange	NASDAQ Exchange
ISIN	US64132R4048
Business Address	545 Concord Avenue,
Sector	Biotechnology
Industry	Health Care
Benchmark	Dow Jones Industrial
Website	www.metaviatx.com
Phone	857 702 9600

MetaVia Key Financial Ratios

	Return On Equity	-1.68
	EBITDA	(28.79 M)
	Net Income	(27.59 M)
	Book Value Per Share	2.88 X
	Market Capitalization	5.93 M

More Fundamentals

MetaVia Key Balance Sheet Accounts

	2021	2022	2023	2024	2025	2026 (projected)
Total Assets	16.8M	33.5M	22.8M	16.3M	18.7M	16.7M
Other Current Liab	1.3M	11.1M	5.1M	4.3M	5.0M	5.2M
Net Debt	(16.3M)	(33.4M)	(22.2M)	(15.9M)	(14.3M)	(15.0M)
Retained Earnings	(81.8M)	(95.8M)	(108.3M)	(135.9M)	(122.3M)	(116.2M)
Accounts Payable	830K	708K	821K	3.9M	4.5M	4.7M
Cash	16.4M	33.4M	22.4M	16.0M	18.4M	16.1M
Other Current Assets	197K	168K	77K	55K	49.5K	47.0K
Total Liab	2.2M	11.8M	6.1M	8.3M	7.5M	6.4M
Total Current Assets	16.6M	33.5M	22.5M	16.1M	18.5M	16.5M
Short Term Debt	24K	26K	67K	78K	70.2K	66.7K
Common Stock	20K	1K	25K	5K	8.1K	10.6K
Net Invested Capital	14.6M	21.8M	16.7M	7.9M	9.1M	15.0M
Capital Stock	1K	25K	5K	9K	8.1K	9.6K
Net Working Capital	14.4M	21.7M	16.6M	7.8M	9.0M	14.9M

MetaVia Key Cash Accounts

	2021	2022	2023	2024	2025	2026 (projected)
Change In Cash	6.3M	17.0M	(10.9M)	(6.4M)	(5.8M)	(5.5M)
Free Cash Flow	(15.1M)	(11.7M)	(10.8M)	(24.7M)	(22.2M)	(21.1M)
Other Non Cash Items	24K	2.5M	(3.0M)	(293K)	(337.0K)	(320.1K)
Net Income	(15.3M)	(14.0M)	(12.5M)	(27.6M)	(24.8M)	(26.1M)
End Period Cash Flow	16.4M	33.4M	22.4M	16.0M	18.4M	16.2M
Depreciation	46K	48K	20K	6K	18K	20.9K
Investments	(586K)	8K	(50K)	(8K)	(9.2K)	(9.7K)

MetaVia Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining MetaVia's current stock value. Our valuation model uses many indicators to compare MetaVia value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across MetaVia competition to find correlations between indicators driving MetaVia's intrinsic value. More Info.

MetaVia is regarded fifth in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, MetaVia's Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the MetaVia's earnings, one of the primary drivers of an investment's value.

Most indicators from MetaVia's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into MetaVia current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MetaVia. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in small area income & poverty estimates.

For information on how to trade MetaVia Stock refer to our How to Trade MetaVia Stock guide.As of February 11, 2026, Selling General Administrative is expected to decline to about 6.3 M. In addition to that, Issuance Of Capital Stock is expected to decline to about 18.4 M

	2023	2025	2026 (projected)
Reconciled Depreciation	6K	18K	22.4K
Cost Of Revenue	7K	21.6K	31.7K

Reconciled Depreciation Cost Of Revenue

MetaVia fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Common Stock Shares Outstanding	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Non Currrent Assets Other	Non Current Liabilities Total	Property Plant And Equipment Net	Capital Lease Obligations	Net Invested Capital	Property Plant And Equipment Gross	Capital Stock	Net Working Capital
Total Assets		0.06	0.69	0.71	0.84	-0.95	-0.74	0.5	1.0	0.0	1.0	0.35	0.21	0.74	0.3	1.0	-0.32	0.36	-0.81	-0.71	0.31	-0.04	0.68	-0.67	-0.28	0.68
Short Long Term Debt Total	0.06		-0.45	0.0	-0.28	0.18	0.29	0.06	0.04	-0.02	0.04	-0.33	0.72	-0.28	0.62	0.06	0.67	0.38	-0.15	0.48	-0.46	-0.1	-0.34	0.34	0.33	-0.34
Other Current Liab	0.69	-0.45		0.76	0.71	-0.79	-0.63	0.37	0.71	0.13	0.71	0.43	-0.49	0.69	-0.04	0.69	-0.65	0.13	-0.26	-0.78	0.2	-0.05	0.68	-0.77	-0.21	0.68
Total Current Liabilities	0.71	0.0	0.76		0.38	-0.62	-0.7	0.55	0.71	0.36	0.71	0.48	-0.14	0.75	0.57	0.71	-0.12	0.31	-0.43	-0.5	0.07	0.02	0.5	-0.75	-0.16	0.51
Total Stockholder Equity	0.84	-0.28	0.71	0.38		-0.95	-0.59	0.3	0.85	-0.19	0.85	0.24	-0.02	0.57	-0.27	0.84	-0.7	0.14	-0.61	-0.86	0.44	-0.02	0.61	-0.51	-0.32	0.61
Net Debt	-0.95	0.18	-0.79	-0.62	-0.95		0.72	-0.4	-0.95	0.05	-0.95	-0.35	-0.03	-0.72	-0.02	-0.95	0.53	-0.25	0.7	0.84	-0.39	0.05	-0.72	0.68	0.31	-0.72
Retained Earnings	-0.74	0.29	-0.63	-0.7	-0.59	0.72		-0.74	-0.75	-0.12	-0.75	-0.79	0.08	-0.97	-0.24	-0.74	0.38	0.03	0.76	0.71	-0.53	-0.32	-0.59	0.7	0.67	-0.59
Accounts Payable	0.5	0.06	0.37	0.55	0.3	-0.4	-0.74		0.49	0.03	0.49	0.73	0.11	0.77	0.28	0.49	-0.27	0.11	-0.61	-0.47	0.28	0.31	0.08	-0.37	-0.4	0.08
Cash	1.0	0.04	0.71	0.71	0.85	-0.95	-0.75	0.49		-0.02	1.0	0.35	0.19	0.74	0.28	1.0	-0.34	0.35	-0.8	-0.71	0.31	-0.04	0.69	-0.68	-0.28	0.69
Non Current Assets Total	0.0	-0.02	0.13	0.36	-0.19	0.05	-0.12	0.03	-0.02		-0.02	0.09	-0.19	0.22	0.32	-0.02	0.25	-0.09	0.01	-0.2	0.38	0.2	-0.03	0.1	-0.18	-0.04
Cash And Short Term Investments	1.0	0.04	0.71	0.71	0.85	-0.95	-0.75	0.49	1.0	-0.02		0.35	0.19	0.74	0.28	1.0	-0.34	0.35	-0.8	-0.71	0.31	-0.04	0.69	-0.68	-0.28	0.69
Common Stock Shares Outstanding	0.35	-0.33	0.43	0.48	0.24	-0.35	-0.79	0.73	0.35	0.09	0.35		-0.31	0.82	0.09	0.34	-0.28	-0.3	-0.4	-0.47	0.34	0.6	0.29	-0.53	-0.65	0.29
Other Current Assets	0.21	0.72	-0.49	-0.14	-0.02	-0.03	0.08	0.11	0.19	-0.19	0.19	-0.31		-0.14	0.43	0.21	0.5	0.55	-0.53	0.23	-0.01	-0.16	-0.19	0.23	0.24	-0.19
Other Stockholder Equity	0.74	-0.28	0.69	0.75	0.57	-0.72	-0.97	0.77	0.74	0.22	0.74	0.82	-0.14		0.25	0.74	-0.37	-0.04	-0.7	-0.74	0.49	0.3	0.6	-0.71	-0.65	0.6
Total Liab	0.3	0.62	-0.04	0.57	-0.27	-0.02	-0.24	0.28	0.28	0.32	0.28	0.09	0.43	0.25		0.29	0.68	0.43	-0.35	0.28	-0.22	-0.07	0.13	-0.26	0.1	0.14
Total Current Assets	1.0	0.06	0.69	0.71	0.84	-0.95	-0.74	0.49	1.0	-0.02	1.0	0.34	0.21	0.74	0.29		-0.33	0.36	-0.81	-0.7	0.3	-0.05	0.68	-0.68	-0.28	0.68
Short Term Debt	-0.32	0.67	-0.65	-0.12	-0.7	0.53	0.38	-0.27	-0.34	0.25	-0.34	-0.28	0.5	-0.37	0.68	-0.33		0.18	0.1	0.72	-0.39	-0.08	-0.29	0.29	0.28	-0.29
Common Stock	0.36	0.38	0.13	0.31	0.14	-0.25	0.03	0.11	0.35	-0.09	0.35	-0.3	0.55	-0.04	0.43	0.36	0.18		-0.31	0.01	-0.14	-0.55	0.06	-0.27	0.72	0.06
Non Currrent Assets Other	-0.81	-0.15	-0.26	-0.43	-0.61	0.7	0.76	-0.61	-0.8	0.01	-0.8	-0.4	-0.53	-0.7	-0.35	-0.81	0.1	-0.31		0.54	-0.56	-0.12	-0.42	0.42	0.4	-0.42
Non Current Liabilities Total	-0.71	0.48	-0.78	-0.5	-0.86	0.84	0.71	-0.47	-0.71	-0.2	-0.71	-0.47	0.23	-0.74	0.28	-0.7	0.72	0.01	0.54		-0.65	-0.14	-0.49	0.49	0.47	-0.49
Property Plant And Equipment Net	0.31	-0.46	0.2	0.07	0.44	-0.39	-0.53	0.28	0.31	0.38	0.31	0.34	-0.01	0.49	-0.22	0.3	-0.39	-0.14	-0.56	-0.65		0.39	0.17	-0.03	-0.53	0.17
Capital Lease Obligations	-0.04	-0.1	-0.05	0.02	-0.02	0.05	-0.32	0.31	-0.04	0.2	-0.04	0.6	-0.16	0.3	-0.07	-0.05	-0.08	-0.55	-0.12	-0.14	0.39		-0.17	0.2	-0.59	-0.17
Net Invested Capital	0.68	-0.34	0.68	0.5	0.61	-0.72	-0.59	0.08	0.69	-0.03	0.69	0.29	-0.19	0.6	0.13	0.68	-0.29	0.06	-0.42	-0.49	0.17	-0.17		-0.78	-0.34	1.0
Property Plant And Equipment Gross	-0.67	0.34	-0.77	-0.75	-0.51	0.68	0.7	-0.37	-0.68	0.1	-0.68	-0.53	0.23	-0.71	-0.26	-0.68	0.29	-0.27	0.42	0.49	-0.03	0.2	-0.78		0.16	-0.78
Capital Stock	-0.28	0.33	-0.21	-0.16	-0.32	0.31	0.67	-0.4	-0.28	-0.18	-0.28	-0.65	0.24	-0.65	0.1	-0.28	0.28	0.72	0.4	0.47	-0.53	-0.59	-0.34	0.16		-0.34
Net Working Capital	0.68	-0.34	0.68	0.51	0.61	-0.72	-0.59	0.08	0.69	-0.04	0.69	0.29	-0.19	0.6	0.14	0.68	-0.29	0.06	-0.42	-0.49	0.17	-0.17	1.0	-0.78	-0.34

Click cells to compare fundamentals

MetaVia Account Relationship Matchups

MetaVia fundamental ratios Accounts

	2021	2022	2023	2024	2025	2026 (projected)
Total Assets	16.8M	33.5M	22.8M	16.3M	18.7M	16.7M
Other Current Liab	1.3M	11.1M	5.1M	4.3M	5.0M	5.2M
Net Debt	(16.3M)	(33.4M)	(22.2M)	(15.9M)	(14.3M)	(15.0M)
Retained Earnings	(81.8M)	(95.8M)	(108.3M)	(135.9M)	(122.3M)	(116.2M)
Accounts Payable	830K	708K	821K	3.9M	4.5M	4.7M
Cash	16.4M	33.4M	22.4M	16.0M	18.4M	16.1M
Other Current Assets	197K	168K	77K	55K	49.5K	47.0K
Total Liab	2.2M	11.8M	6.1M	8.3M	7.5M	6.4M
Total Current Assets	16.6M	33.5M	22.5M	16.1M	18.5M	16.5M
Short Term Debt	24K	26K	67K	78K	70.2K	66.7K
Common Stock	20K	1K	25K	5K	8.1K	10.6K
Net Invested Capital	14.6M	21.8M	16.7M	7.9M	9.1M	15.0M
Capital Stock	1K	25K	5K	9K	8.1K	9.6K
Net Working Capital	14.4M	21.7M	16.6M	7.8M	9.0M	14.9M

Today, most investors in MetaVia Stock are looking for potential investment opportunities by analyzing not only static indicators but also various MetaVia's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of MetaVia growth as a starting point in their analysis.

Price Earnings To Growth Ratio

(0.0139)

At present, MetaVia's Price Earnings To Growth Ratio is projected to slightly decrease based on the last few years of reporting.

MetaVia February 11, 2026 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of MetaVia help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of MetaVia. We use our internally-developed statistical techniques to arrive at the intrinsic value of MetaVia based on widely used predictive technical indicators. In general, we focus on analyzing MetaVia Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build MetaVia's daily price indicators and compare them against related drivers.

	Information Ratio	(0.20)
	Maximum Drawdown	79.95
	Value At Risk	(20.10)
	Potential Upside	11.6

Complementary Tools for MetaVia Stock analysis

When running MetaVia's price analysis, check to measure MetaVia's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MetaVia is operating at the current time. Most of MetaVia's value examination focuses on studying past and present price action to predict the probability of MetaVia's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MetaVia's price. Additionally, you may evaluate how the addition of MetaVia to your portfolios can decrease your overall portfolio volatility.

	Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk
	Risk-Return Analysis View associations between returns expected from investment and the risk you assume
	Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities
	Money Managers Screen money managers from public funds and ETFs managed around the world
	Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
	Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
	Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
	Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account
	Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

MetaVia Financials

MetaVia Balance Sheet Chart

Net Income

(26.07 Million)

MetaVia Stock Summary

MetaVia Key Financial Ratios

MetaVia Key Balance Sheet Accounts

MetaVia Key Cash Accounts

MetaVia Financial Ratios Relationships

MetaVia fundamental ratios Correlations

MetaVia Account Relationship Matchups

High Positive Relationship

High Negative Relationship

MetaVia fundamental ratios Accounts

Price Earnings To Growth Ratio

(0.0139)

MetaVia February 11, 2026 Opportunity Range

Complementary Tools for MetaVia Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash And Short Term Investments

Other Stockholder Equity	- 0.97	Retained Earnings
Total Current Assets	- 0.95	Net Debt
Cash And Short Term Investments	- 0.95	Net Debt
Cash	- 0.95	Net Debt
Net Debt	- 0.95	Total Stockholder Equity
Net Debt	- 0.95	Total Assets